Latest Articles & Resources FEATURED Oncodesign Services Expands Radiopharmaceutical CRO Capabilities With ARRONAX Deal Read More » Oncodesign Services Expands Radiopharmaceutical CRO Capabilities With ARRONAX Deal Read More » LATEST NEWS + INTERVIEWS Delpharm Secures ANVISA Certification for Évreux Site CEPI and Analysis Zero(A Recipharm Company) Launch NMR-Based RNA Vaccine Manufacturing Project Eurofins CDMO Alphora Expands API Manufacturing with Continuous Flow Technology Piramal Pharma Solutions Partners with Ajinomoto to Expand ADC Manufacturing Capabilities RyghtAI Launches Clinical Trial Site Search Engine for CROs Novartis on What Great CDMO Partnerships Actually Look Like Adragos Pharma Signs Agreement with Towa to Supply Up to 1.5 Billion Tablets Annually SQ Innovation Secures Long-Term API Supply from FIS for Lasix ONYU Biointron Expands CRO Capabilities With Antibody Developability Assessment Platform FUJIFILM Biotechnologies Opens 2,000 m² QC Laboratory in Denmark Forlong Biotechnology Advances FL115 Program with GMP Manufacturing Transfer Completion NorthStar Medical Radioisotopes Secures FDA Acceptance for Ac-225 Drug Master File Curative Biotechnology Engages Sterling for Clinical Manufacturing of Ophthalmic Therapy Ardena Launches 2,500 Sq Ft Bioanalytical Laboratory in New Jersey Achieve Life Sciences Transfers Cytisinicline Manufacturing to Adare Pharma Solutions in the U.S. WuXi Biologics Achieves ISO 13485 Certification with Zero Non-Conformities Apotex Secures Sterile Filling Partnership with Halo Pharmaceuticals in New Jersey Clarity Pharmaceuticals Signs Commercial Manufacturing Agreement with Nucleus Radiopharma Kincell Bio Expands RTP Facility with Two New Cleanroom Suites for Cell Therapy Manufacturing Grand River Aseptic Manufacturing Invests $100M in Fifth GMP Facility and Filling Line 57% of Pharma Companies Outsource All Their Sterile Injectable Manufacturing PODCAST INTERVIEWS Novartis on What Great CDMO Partnerships Actually Look Like How Eramol’s Purpose-Built Sterile Facility Targets Less Than 1% Material Loss for Biotech Clients Delpharm CEO: Every Day Lost in Clinical Manufacturing Is a Day of Peak Sales Gone Forever
